Reaction
Implantable Defibrillator Insertion reporting signals
As of the last recalculation, Implantable Defibrillator Insertion appears in 1,298 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is RANOLAZINE (PRR 108.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranolazine | 67 | 108.5 | 109.2 |
| Dofetilide | 12 | 18.5 | 18.5 |
| Digoxin | 75 | 17.7 | 17.7 |
| Sotalol Hydrochloride | 18 | 17.6 | 17.6 |
| Amiodarone Hydrochloride | 12 | 17.3 | 17.3 |
| Carvedilol | 128 | 16.7 | 16.7 |
| Metolazone | 11 | 15.8 | 15.8 |
| Tafamidis | 11 | 15.1 | 15.1 |
| Ezetimibe And Simvastatin | 12 | 12.8 | 12.8 |
| Bosentan | 37 | 12.1 | 12.1 |
| Prasugrel Hydrochloride | 6 | 9.5 | 9.5 |
| Agalsidase Beta | 5 | 8.7 | 8.7 |
| Sacubitril And Valsartan | 32 | 4.5 | 4.5 |
| Alirocumab | 6 | 3.8 | 3.8 |
| Patiromer | 3 | 3.5 | 3.5 |
| Evolocumab | 19 | 1.9 | 1.9 |